Filing Flows

Filing Flows › SeaStar Medical Holding (ICU) › Who owns the stock

Who owns SeaStar Medical Holding (ICU) stock

17 funds reported SeaStar Medical Holding (ICU) shares in their latest 13F filings, worth $566K in all. The largest holder is Geode Capital Management, LLC ($182K). Last quarter 4 funds added to their stakes and 5 cut them.

Largest holders of ICU (13F)Largest holders of ICU (13F)Geode Capital Management, LLC$182KVanguard Capital Management LLC$121KUBS Group AG$115KVanguard Fiduciary Trust$50KJane Street Group, LLC$46KNorthern Trust$38KTower Research Capital LLC$5KBlackRock$3KBarclays$2KOsaic Holdings$1K

Largest holders (13F)

FundSharesValueChangeQuarter
Geode Capital Management, LLC49,593$182Kdecrease2026-06-30
Vanguard Capital Management LLC33,091$121Kincrease2026-06-30
UBS Group AG31,398$115Kincrease2026-06-30
Vanguard Fiduciary Trust13,692$50Kunchanged2026-06-30
Jane Street Group, LLC12,634$46Kdecrease2026-06-30
Northern Trust10,402$38Knew2026-06-30
Tower Research Capital LLC1,356$5Kdecrease2026-06-30
BlackRock913$3Kunchanged2026-06-30
Barclays633$2Kincrease2026-09-30
Osaic Holdings195$1Kdecrease2026-06-30
NewEdge Advisors, LLC176$1Kunchanged2026-06-30
Vanguard Global Advisers, LLC165$1Kunchanged2026-06-30
TD Waterhouse Canada22$82unchanged2026-09-30
SBI Securities14$51unchanged2026-06-30
SOA Wealth Advisors, LLC.6$22unchanged2026-06-30

SeaStar Medical Holding's latest quarter

SeaStar Medical Holding, Q2 2026: revenue $615K (+82% year over year), operating margin -616.4%, net loss $3.7M, operating cash flow −$3.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most ICU stock?

By the latest 13F filings: Geode Capital Management, LLC ($182K); Vanguard Capital Management LLC ($121K); UBS Group AG ($115K); Vanguard Fiduciary Trust ($50K); Jane Street Group, LLC ($46K).

What is the short interest in ICU?

185,839 shares were sold short at the 2026-10-15 settlement, 29.3% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.